All News about Sab Biotherapeutics Inc
![](https://ml.globenewswire.com/media/6d99a771-f2c9-4d05-bf57-4f6c070df032/small/sabprimarylogocolorrgb900px72ppi-png.png)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://ml.globenewswire.com/media/6d99a771-f2c9-4d05-bf57-4f6c070df032/small/sabprimarylogocolorrgb900px72ppi-png.png)
![](https://ml.globenewswire.com/media/6d99a771-f2c9-4d05-bf57-4f6c070df032/small/sabprimarylogocolorrgb900px72ppi-png.png)
![](https://ml.globenewswire.com/media/6d99a771-f2c9-4d05-bf57-4f6c070df032/small/sabprimarylogocolorrgb900px72ppi-png.png)
SAB BIO Appoints Lucy To as Chief Financial Officer
July 31, 2024
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://www.globenewswire.com/Content/Images/intrado.png)
SAb Biotherapeutics Rebrands as SAB BIO
June 20, 2024
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://ml.globenewswire.com/media/4bc8f1d6-1a54-4ee4-a3d7-d8c6d4353f18/small/sab-logo-png.png)
![](https://ml.globenewswire.com/media/4bc8f1d6-1a54-4ee4-a3d7-d8c6d4353f18/small/sab-logo-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://ml.globenewswire.com/media/4bc8f1d6-1a54-4ee4-a3d7-d8c6d4353f18/small/sab-logo-png.png)
![](https://ml.globenewswire.com/media/4bc8f1d6-1a54-4ee4-a3d7-d8c6d4353f18/small/sab-logo-png.png)
![](https://ml.globenewswire.com/media/4bc8f1d6-1a54-4ee4-a3d7-d8c6d4353f18/small/sab-logo-png.png)
![](https://ml.globenewswire.com/media/4bc8f1d6-1a54-4ee4-a3d7-d8c6d4353f18/small/sab-logo-png.png)
SAB Biotherapeutics Provides SAB-142 Trial Update
April 16, 2024
Via GlobeNewswire
![](https://ml.globenewswire.com/media/4bc8f1d6-1a54-4ee4-a3d7-d8c6d4353f18/small/sab-logo-png.png)
SAB Biotherapeutics to Present at INNODIA Annual Meeting
April 08, 2024
Via GlobeNewswire
![](https://ml.globenewswire.com/media/4bc8f1d6-1a54-4ee4-a3d7-d8c6d4353f18/small/sab-logo-png.png)
![](https://ml.globenewswire.com/media/4bc8f1d6-1a54-4ee4-a3d7-d8c6d4353f18/small/sab-logo-png.png)
![](https://ml.globenewswire.com/media/4bc8f1d6-1a54-4ee4-a3d7-d8c6d4353f18/small/sab-logo-png.png)
SAB Biotherapeutics to Present at the BIO CEO & Investor Conference
February 23, 2024
Via GlobeNewswire
![](https://ml.globenewswire.com/media/4bc8f1d6-1a54-4ee4-a3d7-d8c6d4353f18/small/sab-logo-png.png)
![](https://ml.globenewswire.com/media/4bc8f1d6-1a54-4ee4-a3d7-d8c6d4353f18/small/sab-logo-png.png)
SAB Biotherapeutics Announces Executive Leadership Change
February 02, 2024
Via GlobeNewswire
![](https://ml.globenewswire.com/media/4bc8f1d6-1a54-4ee4-a3d7-d8c6d4353f18/small/sab-logo-png.png)
![](https://cdn.benzinga.com/files/images/story/2024/01/05/image31.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/01/03/cal-maine_foods_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/4bc8f1d6-1a54-4ee4-a3d7-d8c6d4353f18/small/sab-logo-png.png)
SAB Biotherapeutics Announces 1-for-10 Reverse Stock Split
January 02, 2024
Via GlobeNewswire
![](/next-assets/images/schema-image-default.png)
VerifyMe And 3 Other Stocks Under $2 Insiders Are Buying
December 01, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://ml.globenewswire.com/media/4bc8f1d6-1a54-4ee4-a3d7-d8c6d4353f18/small/sab-logo-png.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.